BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15013374)

  • 1. Leptin is a growth factor in cancer.
    Somasundar P; McFadden DW; Hileman SM; Vona-Davis L
    J Surg Res; 2004 Feb; 116(2):337-49. PubMed ID: 15013374
    [No Abstract]   [Full Text] [Related]  

  • 2. [5-hydroxytryptamine and neoplasm growth].
    Rudzit EA; Mal'tseva LF
    Patol Fiziol Eksp Ter; 1970; 14(4):84-93. PubMed ID: 4927762
    [No Abstract]   [Full Text] [Related]  

  • 3. Leptin signaling in breast cancer: an overview.
    Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
    J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance of adiponectin and leptin modulates breast cancer cell growth.
    Grossmann ME; Ray A; Dogan S; Mizuno NK; Cleary MP
    Cell Res; 2008 Nov; 18(11):1154-6. PubMed ID: 18957939
    [No Abstract]   [Full Text] [Related]  

  • 5. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
    Perrier S; Caldefie-Chézet F; Vasson MP
    FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of lipid metabolism on prostate cancer development and progression: is it time for a closer look?
    Clarke NW; Brown MD
    Eur Urol; 2007 Jul; 52(1):3-4. PubMed ID: 17467164
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth factors in prostatic cancer].
    Wada F
    Gan No Rinsho; 1989 May; Spec No():253-60. PubMed ID: 2689665
    [No Abstract]   [Full Text] [Related]  

  • 12. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN; Chin HG; Duru N; Camarillo IG
    J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.
    Nicholson RI; Staka C; Boyns F; Hutcheson IR; Gee JM
    Endocr Relat Cancer; 2004 Dec; 11(4):623-41. PubMed ID: 15613443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
    Harvie M; Howell A
    Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies.
    Nicholson RI; Hutcheson IR; Britton D; Knowlden JM; Jones HE; Harper ME; Hiscox SE; Barrow D; Gee JM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):257-62. PubMed ID: 15860268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivascular therapy of cancer metastasis.
    Fidler IJ
    J Surg Oncol; 2006 Sep; 94(3):178-80. PubMed ID: 16900530
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
    Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin as a growth inhibitor in prostate cancer cells.
    Bub JD; Miyazaki T; Iwamoto Y
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1158-66. PubMed ID: 16403434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity hormone leptin: a new target in breast cancer?
    Surmacz E
    Breast Cancer Res; 2007; 9(1):301. PubMed ID: 17274833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyblastomatosis of hormone-dependent organs].
    Lodi A; Ravaglia G; Monti D; Ravaioli R; Rimondi S; Lenzi S
    G Clin Med; 1976; 57(1-2):15-45. PubMed ID: 1035179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.